Prognostic factors and treatment outcomes in patients with operated endometrial cancer: Analysis of 674 patients at a single institution

Journal of B.U.ON.

Volumn 16, Issue 1, 2011, Pages 64-73

  Yoney, Adnan ^a   Yildirim, C ^a   Isikli, L ^a   Unsal, M ^a  

^a Okmeydani Training and Research Hospital ^*  (Turkey)

Author keywords

Endometrial carcinoma; Grade; Myometrial invasion; Postoperative treatment

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EVALUATION; CYTOLOGY; DISEASE FREE SURVIVAL; ENDOCAVITARY RADIOTHERAPY; ENDOMETRIUM CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 79954527184     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Kong A, Simera I, Collingwood M et al. Cochrane Gynaecological Cancer Group. Adjuvant radiotherapy for stage I endometrial cancer: systematic review and meta-analysis. Ann Oncol 2007; 18: 1595-1604.
2. Baekelandt MM, Castiglione M. ESMO Guidelines Working Group. Endometrial carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009; 20 (Suppl 4): 29-31.
3. American College of Obstetricians and Gynecologists. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol 2005; 106: 413-425.
4. Pitson G, Colgan T, Levin W et al. Stage II endometrial carcinoma: prognostic factors and risk classification in 170 patients. Int J Radiat Oncol Biol Phys 2002; 53: 862-867. (Pubitemid 34722630)
5. Creutzberg CL, van Putten WL, Koper PC et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage 1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000; 355: 1404-1411.
6. Keys HM, Roberts JA, Brunetto VL et al. Gynecologic Oncology Group. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004; 92: 744-751.
7. Aalders J, Abeler V, Kolstad P et al. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 1980; 56: 419-427. (Pubitemid 10018299)
8. Jolly S, Vargas C, Kumar T et al. Vaginal brachytherapy alone: an alternative to adjuvant whole pelvic radiation for early stage endometrial cancer. Gynecol Oncol 2005; 97: 887-892. (Pubitemid 40824661)
9. Petereit DG, Tannehill SP, Grosen EA et al. Outpatient vaginal cuff brachytherapy for endometrial cancer. Int J Gynecol Cancer 1999; 9: 456-462. (Pubitemid 30027548)
10. Stanojevic Z, Djordjevic B, Todorosvska I et al. Risk factors and adjuvant chemotherapy in the treatment of endometrial cancer. J BUON 2008; 13: 23-30. (Pubitemid 351460872)
11. Alvarez Secord A, Havrilesky LJ, Bae-Jump V et al. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer. Gynecol Oncol 2007; 107: 285-291. (Pubitemid 47575727)
12. Whitney CW, Brunetto VL, Zaino RJ et al. Gynecologic Oncology Group study. Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004; 92: 4-9.
13. Zaino RJ, Kurman RJ, Diana KL et al. The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. A Gynecologic Oncology Group study. Cancer 1995; 75: 81-86.
14. Chen JL, Trost DC, Wilkinson EJ. Endometrial papillary adenocarcinomas: two clinicopathological types. Int J Gynecol Pathol 1985; 4: 279-288. (Pubitemid 16175327)
15. Clement PB, Young RH. Non-endometrioid carcinomas of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol 2004; 11: 117-142.
16. Abeler VM, Vergote IB, Kjørstad KE et al. Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern. Cancer 1996; 78: 1740-1747.
17. Morrow CP, Bundy BN, Kurman RJ et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991; 40: 55-65.
18. O'Hanlan KA, Levine PA, Harbatkin D et al. Virulence of papillary endometrial carcinoma. Gynecol Oncol 1990; 37: 112-119. (Pubitemid 20147981)
19. Hoekstra AV, Kim RJ, Small W Jr et al. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes. Gynecol Oncol 2009; 114: 273-278.
20. Jolly S, Vargas CE, Kumar T et al. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation. Gynecol Oncol 2006; 103: 87-93. (Pubitemid 44374671)
21. Alektiar KM, Venkatraman E, Abu-Rustum N et al. Is endometrial carcinoma intrinsically more aggressive in elderly patients? Cancer 2003; 98: 2368-2377.
22. Scholten AN, Creutzberg CL, Noordijk EM et al. Long-term outcome in endometrial carcinoma favors a two- instead of a three-tiered grading system. Int J Radiat Oncol Biol Phys 2002; 52: 1067-1074. (Pubitemid 34219028)
23. Chan JK, Urban R, Cheung MK et al. Lymphadenectomy in endometrioid uterine cancer staging: How many lymph nodes are enough? A study of 11,443 patients. Cancer 2007; 109: 2454-2460. (Pubitemid 46906464)
24. Mariani A, Dowdy SC, Cliby WA et al. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Gynecol Oncol 2006; 101: 200-208.
25. Lutman CV, Havrilesky LJ, Cragun JM et al. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol 2006; 102: 92-97. (Pubitemid 43870232)
26. Kitchener H, Swart AM, Qian Q et al. ASTEC study group. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRCASTEC trial): A randomised study. Lancet 2009; 373: 125-136.
27. Sorbe B, Nordström B, Mäenpää J et al. Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study. Int J Gynecol Cancer 2009; 19: 873-878.
28. Lin LL, Mutch DG, Rader JS et al. External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer. Gynecol Oncol 2007; 106: 215-220. (Pubitemid 46898597)
29. Jhingran A, Burke TW, Eifel PJ. Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. Int J Radiat Oncol Biol Phys 2003; 56: 1366-1372. (Pubitemid 36842889)
30. Nout RA, Smit VT, Putter H et al. PORTEC Study Group. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet 2010; 375: 816-823.
31. Lee CM, Szabo A, Shrieve DC et al. Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. JAMA 2006; 295: 389-397. (Pubitemid 43144975)
32. Blake P, Swart AM, Orton J et al. ASTEC/EN.5 Study Group. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet 2009; 373: 137-146.
33. Susumu N, Sagae S, Udagawa Y et al. Japanese Gynecologic Oncology Group. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study. Gynecol Oncol 2008; 108: 226-233.
34. Netherlands trial register: Randomized phase III trial comparing concurrent chemoradiation and adjuvant chemotherapy with pelvic radiation alone in high risk and advanced stage endometrial carcinoma: PORTEC-3. [Internet] Leiden, 2006. Available from: http://www.trialregister.nl/trialreg/admin/rc- tview.asp? TC=729. Accessed January 30, 2010.
35. Maggi R, Lissoni A, Spina F et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer 2006; 95: 266-271. (Pubitemid 44187586)
36. Mundt AJ, McBride R, Rotmensch J et al. Significant pelvic recurrence in high-risk pathologic stage I-IV endometrial carcinoma patients after adjuvant chemotherapy alone: Implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 2001; 50: 1145-1153. (Pubitemid 32727790)
37. Frigerio L, Mangili G, Aletti G et al. Concomitant radiotherapy and paclitaxel for high-risk endometrial cancer: first feasibility study. Gynecol Oncol 2001; 81: 53-57. (Pubitemid 32368077)
38. Sutton G, Axelrod JH, Bundy BN et al. Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a Gynecologic Oncology Group study. Gynecol Oncol 2005; 97: 755-763. (Pubitemid 40824643)
39. Gocheva L, Slavchev B. Whole abdominal irradiation in endometrial cancer - a single institution study. J BUON 2009; 14: 613-618.
40. Randall ME, Filiaci VL, Muss H et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group study. J Clin Oncol 2006; 24: 36-44. (Pubitemid 46630491)
41. McMeekin DS, Walker JL, Hartenbach EM et al. Gynecologic Oncology Group. Phase I trial of the treatment of high-risk endometrial cancer with concurrent weekly paclitaxel and cisplatin and whole abdominal radiation therapy: A Gynecologic Oncology Group study. Gynecol Oncol 2009; 112: 134-141.
42. Alektiar KM, Makker V, Abu-Rustum NR et al. Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer. Gynecol Oncol 2009; 112: 142-145.
43. Greven K, Winter K, Underhill K et al. Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol 2006; 103: 155-159. (Pubitemid 44374683)